BlackRock, Inc. 13D and 13G filings for Spectrum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Spectrum Pharmaceuticals, Inc. SPPI | BlackRock Inc. BLK | 7,878,203 4.400% | -7,976,525 (-50.31%) | Filing |
| 2022-03-09 5:18 pm Sale | 2022-02-28 | 13G | Spectrum Pharmaceuticals, Inc. SPPI | BlackRock Inc. BLK | 15,854,728 9.700% | -14,361,219 (-47.53%) | Filing |
| 2022-01-27 11:00 am Unchanged | 2021-12-31 | 13G | Spectrum Pharmaceuticals, Inc. SPPI | BlackRock Inc. BLK | 30,215,947 18.400% | 0 (Unchanged) | Filing |
| 2022-01-25 3:03 pm Purchase | 2021-12-31 | 13G | Spectrum Pharmaceuticals, Inc. SPPI | BlackRock Inc. BLK | 30,215,947 18.400% | 2,394,968 (+8.61%) | Filing |
| 2021-01-25 4:49 pm Purchase | 2020-12-31 | 13G | Spectrum Pharmaceuticals, Inc. SPPI | BlackRock Inc. BLK | 27,820,979 19.100% | 8,986,386 (+47.71%) | Filing |